Competitors of Orchid Pharma Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| MPS Pharmaa Ltd | 8.20 Cr. | 4.29 | 4.33/2.79 | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 3,352 Cr. | 308 | 390/147 | 63.6 | 20.5 | 0.22 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 60.9 Cr. | 82.1 | 94.9/26.6 | 23.3 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 34.4 Cr. | 23.4 | 27.0/8.74 | 44.6 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
| Godavari Drugs Ltd | 87.5 Cr. | 116 | 155/87.0 | 13.1 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 12,012 Cr. | 984 | 1,335/647 | 28.4 | 207 | 2.29 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 358 Cr. | 15.7 | 29.0/13.2 | 20.7 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 9.01 Cr. | 18.6 | 27.1/15.0 | 180 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 347 Cr. | 738 | 1,054/650 | 19.6 | 278 | 0.09 % | 17.1 % | 14.3 % | 10.0 |
| Fervent Synergies Ltd | 63.3 Cr. | 21.1 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 1,116 Cr. | 379 | 440/145 | 136 | 98.6 | 0.33 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 6.52 Cr. | 31.0 | 43.8/23.6 | 130 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 19.9 Cr. | 7.99 | 19.4/7.17 | 44.2 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 236 Cr. | 295 | 295/110 | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 189 Cr. | 2.03 | 3.03/1.03 | 255 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 26.0 Cr. | 10.8 | 14.5/6.40 | 31.4 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 15.2 Cr. | 15.1 | 25.8/14.4 | 18.3 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 278 Cr. | 778 | 999/345 | 11.9 | 570 | 0.26 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 37.1 Cr. | 37.1 | 61.5/30.6 | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 | |
| Colinz Laboratories Ltd | 31.7 Cr. | 69.3 | 84.4/36.0 | 57.6 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 10.2 Cr. | 4.10 | 26.5/4.10 | 41.0 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.1 Cr. | 108 | 154/52.2 | 12.9 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 7.43 Cr. | 13.6 | 17.4/4.42 | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 50.6 Cr. | 67.1 | 148/63.0 | 32.0 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 7.34 Cr. | 24.5 | 27.8/14.6 | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 101 Cr. | 23.4 | 42.0/22.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 18.9 Cr. | 37.2 | 46.0/22.1 | 55.6 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 196 Cr. | 341 | 418/197 | 20.2 | 110 | 1.32 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 34.0 Cr. | 57.7 | 62.6/6.26 | 87.2 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 73,617 Cr. | 1,256 | 1,593/958 | 20.2 | 527 | 0.36 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 171 Cr. | 274 | 307/120 | 27.7 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 1,082 Cr. | 215 | 265/146 | 18.3 | 60.5 | 1.16 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 58.6 Cr. | 44.9 | 86.1/43.0 | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 9,261 Cr. | 2,262 | 2,327/1,004 | 99.2 | 294 | 0.13 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 8.32 Cr. | 1.26 | 1.45/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 430 Cr. | 56.1 | 77.7/37.5 | 32.3 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 13.0 Cr. | 22.2 | 29.0/11.9 | 2.70 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 80.8 Cr. | 3.43 | 6.25/2.87 | 122 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
| Abbott India Ltd | 60,878 Cr. | 28,597 | 30,521/22,500 | 47.4 | 1,657 | 1.43 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,743 Cr. | 632 | 722/381 | 25.2 | 205 | 0.47 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 155 Cr. | 55.5 | 75.8/37.0 | 22.4 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
| Zota Health Care Ltd | 2,292 Cr. | 836 | 859/440 | 58.0 | 0.12 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 23,733 Cr. | 1,460 | 1,537/403 | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 877 Cr. | 267 | 325/122 | 31.8 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 0.66 | 0.00 % | 9.38 % | 233 % | 2.00 | |
| Venus Remedies Ltd | 410 Cr. | 306 | 430/280 | 18.6 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 4,888 Cr. | 697 | 950/401 | 97.7 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 2,001 Cr. | 1,424 | 1,923/1,232 | 30.9 | 735 | 0.70 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,15,729 Cr. | 3,421 | 3,591/2,248 | 66.5 | 222 | 0.82 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,434 Cr. | 265 | 317/181 | 45.9 | 44.8 | 0.19 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,862 Cr. | 19.8 | 27.9/11.0 | 58.6 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 29,242 Cr. | 1,148 | 1,360/585 | 120 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,857 Cr. | 131 | 169/80.0 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,42,142 Cr. | 1,841 | 1,960/1,250 | 39.4 | 288 | 0.73 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,953 Cr. | 683 | 886/322 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 1,957 Cr. | 231 | 398/118 | 33.3 | 70.6 | 0.17 % | 11.2 % | 9.27 % | 1.00 |
| SMS Lifesciences India Ltd | 363 Cr. | 1,202 | 1,750/495 | 17.9 | 621 | 0.12 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 7,491 Cr. | 765 | 960/313 | 130 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 4,319 Cr. | 173 | 241/91.8 | 203 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 14,066 Cr. | 6,095 | 7,600/4,606 | 33.4 | 298 | 2.74 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,542 Cr. | 2,141 | 2,977/1,306 | 40.7 | 229 | 0.75 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,058 Cr. | 5,449 | 5,850/4,637 | 40.0 | 324 | 1.10 % | 45.0 % | 33.5 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 215 Cr. | 60.9 | 87.5/31.9 | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 22,282 Cr. | 4,875 | 6,453/3,950 | 36.4 | 820 | 0.72 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 252 Cr. | 205 | 348/190 | 13.8 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,743 Cr. | 449 | 491/112 | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 9,019 Cr. | 1,778 | 1,850/702 | 75.8 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 17,226 Cr. | 13,438 | 18,100/5,021 | 65.2 | 1,087 | 0.10 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 875 Cr. | 39.5 | 56.5/26.2 | 81.6 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 24,386 Cr. | 1,362 | 1,639/792 | 12.5 | 399 | 0.70 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,233 Cr. | 77.2 | 101/38.6 | 32.2 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,153 Cr. | 290 | 359/126 | 38.0 | 50.3 | 0.21 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 180 Cr. | 114 | 145/85.2 | 19.1 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 532 Cr. | 149 | 177/97.9 | 168 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
| Lupin Ltd | 99,600 Cr. | 2,182 | 2,312/1,289 | 37.9 | 343 | 0.37 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,572 Cr. | 787 | 980/498 | 16.3 | 319 | 0.23 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 30,764 Cr. | 571 | 593/359 | 131 | 79.2 | 0.14 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 911 Cr. | 878 | 961/381 | 26.5 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 207 Cr. | 95.9 | 129/60.0 | 60.4 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,027 Cr. | 215 | 370/198 | 19.4 | 103 | 1.39 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 519 Cr. | 326 | 470/298 | 36.9 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
| Jubilant Pharmova Ltd | 17,050 Cr. | 1,070 | 1,310/531 | 59.9 | 373 | 0.47 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,004 Cr. | 1,809 | 2,030/1,474 | 45.8 | 207 | 0.68 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,631 Cr. | 616 | 820/270 | 60.9 | 74.4 | 0.81 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 40,437 Cr. | 1,594 | 1,709/1,052 | 64.9 | 264 | 0.25 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,419 Cr. | 411 | 538/331 | 24.1 | 283 | 1.22 % | 12.3 % | 8.68 % | 10.0 |
| Ind-Swift Ltd | 142 Cr. | 26.0 | 32.6/14.3 | 2.58 | 122 | 0.00 % | 13.4 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 618 Cr. | 106 | 186/86.2 | 6.05 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
| Indoco Remedies Ltd | 3,065 Cr. | 332 | 417/286 | 137 | 118 | 0.45 % | 10.4 % | 8.33 % | 2.00 |
| Hikal Ltd | 4,533 Cr. | 368 | 465/260 | 61.7 | 97.6 | 0.33 % | 7.79 % | 5.97 % | 2.00 |
| Hester Biosciences Ltd | 2,038 Cr. | 2,402 | 3,379/1,293 | 86.8 | 355 | 0.25 % | 9.32 % | 6.60 % | 10.0 |
| Gufic BioSciences Ltd | 4,511 Cr. | 451 | 504/278 | 53.1 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
| Granules India Ltd | 14,383 Cr. | 593 | 725/382 | 29.5 | 141 | 0.25 % | 15.4 % | 13.4 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 43,488 Cr. | 1,541 | 1,831/767 | 299 | 0.16 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 37,993 Cr. | 2,243 | 3,088/1,797 | 47.4 | 98.7 | 1.43 % | 51.3 % | 37.3 % | 10.0 |
| Gland Pharma Ltd | 30,049 Cr. | 1,824 | 2,221/1,586 | 27.2 | 557 | 1.10 % | 16.7 % | 12.3 % | 1.00 |
| FDC Ltd | 8,220 Cr. | 504 | 659/390 | 26.0 | 141 | 0.99 % | 18.4 % | 14.2 % | 1.00 |
| ERIS Lifesciences Ltd | 18,416 Cr. | 1,353 | 1,594/809 | 53.0 | 204 | 0.00 % | 11.3 % | 16.3 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,13,046 Cr. | 1,355 | 1,421/1,104 | 21.2 | 369 | 0.59 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,194 Cr. | 268 | 308/133 | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,20,367 Cr. | 1,491 | 1,702/1,240 | 26.1 | 351 | 0.87 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 18,226 Cr. | 2,399 | 2,540/1,221 | 37.0 | 334 | 0.21 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 431 Cr. | 170 | 186/72.5 | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,705 Cr. | 162 | 180/92.2 | 19.3 | 96.0 | 0.31 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 96.7 Cr. | 59.5 | 92.0/53.4 | 182 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 41,559 Cr. | 346 | 396/244 | 28.8 | 175 | 0.14 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,942 Cr. | 2,020 | 2,326/1,060 | 47.4 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 195 Cr. | 121 | 158/89.0 | 25.6 | 43.2 | 0.99 % | 12.1 % | 11.0 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 187 Cr. | 79.2 | 113/73.2 | 243 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 15,946 Cr. | 6,381 | 8,140/4,050 | 124 | 272 | 0.38 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,052 Cr. | 714 | 863/556 | 43.2 | 103 | 0.64 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 243 Cr. | 114 | 145/69.9 | 11.7 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 64,628 Cr. | 5,409 | 6,440/4,407 | 29.7 | 961 | 0.74 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 20,344 Cr. | 1,036 | 1,304/746 | 32.0 | 249 | 1.06 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 746 Cr. | 1,309 | 1,754/960 | 10.9 | 724 | 0.88 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 34,890 Cr. | 2,791 | 3,486/1,981 | 39.9 | 294 | 1.29 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,956 Cr. | 354 | 571/334 | 27.0 | 120 | 1.44 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,204 Cr. | 453 | 635/420 | 33.6 | 126 | 0.22 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 19,110.67 Cr | 1,166.21 | 54.93 | 184.74 | 0.32% | 16.14% | 16.48% | 6.30 |
